Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Infection and Chemotherapy
Published in: Journal of Infection and Chemotherapy 3/2005

01-06-2005 | ORIGINAL ARTICLE

Multicenter prospective study of procalcitonin as an indicator of sepsis

Authors: Naoki Aikawa, Seitaro Fujishima, Shigeatu Endo, Isao Sekine, Kazuhiro Kogawa, Yasuhiro Yamamoto, Shigeki Kushimoto, Hidekazu Yukioka, Noboru Kato, Kyoichi Totsuka, Ken Kikuchi, Toshiaki Ikeda, Kazumi Ikeda, Kazuaki Harada, Shinji Satomura

Published in: Journal of Infection and Chemotherapy | Issue 3/2005

Login to get access
Metadata
Title
Multicenter prospective study of procalcitonin as an indicator of sepsis
Authors
Naoki Aikawa
Seitaro Fujishima
Shigeatu Endo
Isao Sekine
Kazuhiro Kogawa
Yasuhiro Yamamoto
Shigeki Kushimoto
Hidekazu Yukioka
Noboru Kato
Kyoichi Totsuka
Ken Kikuchi
Toshiaki Ikeda
Kazumi Ikeda
Kazuaki Harada
Shinji Satomura
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Journal of Infection and Chemotherapy / Issue 3/2005
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-005-0388-9

Other articles of this Issue 3/2005

Journal of Infection and Chemotherapy 3/2005 Go to the issue

ORIGINAL ARTICLE

Surgical site infection surveillance after open gastrectomy and risk factors for surgical site infection

ORIGINAL ARTICLE

Evaluation of the anti-Trichophyton activity of a prodigiosin analogue produced by γ-proteobacterium, using stratum corneum epidermis of the Yucatan micropig

ORIGINAL ARTICLE

Bacterial food-borne illness outbreaks in northern Taiwan, 1995–2001

ORIGINAL ARTICLE

A murine model of pulmonary basidiomycosis by Schizophyllum commune

CASE REPORT

A case of necrotizing fasciitis caused by coagulase-negative staphylococcus: utility of magnetic resonance imaging for the preoperative diagnosis of necrotizing fasciitis

CASE REPORT

Nocardial epidural abscess of the thoracic spinal cord and review of the literature
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits